http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011052765-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_78794009224b921d8e440c4287c3c81f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3c727a03851b2b2c07e05abe61a746cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68152be9f2748c6822e8f4e42b2ed490
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bd84e43aed5588727d23620677c31860
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c999fee6428152a996011d506925c2d7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
filingDate 2010-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a396dbc605a6806d36f786e5ad577bc6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3d50ac24e8d5f00ed3c65fb74ec57c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee1ec0646a305da43e5652ccc6eb67fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_478ecdbfa8c830d66c6a15626fa8b153
publicationDate 2011-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2011052765-A1
titleOfInvention Alleviator for renal disorders caused by administration of platinum-containing drug
abstract Renal disorders caused by the administration of a platinum-containing drug such as cisplatin can be alleviated.nIn association with the administration of a platinum-containing drug, moisture is loaded by using an infusion solution containing bicarbonate ion such as bicarbonate Ringer's solution.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113646043-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10143710-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014121323-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018193648-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020196381-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7219898-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2018193648-A1
priorityDate 2009-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400643
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3440

Total number of triples: 42.